The half-maximum activation voltage was Ϫ7.8 Ϯ 2.4 mV at 23°C, shifting to Ϫ31.9 Ϯ 1.2 mV at 36°C. Channels activated with a time constant of 13 Ϯ 1 ms at ϩ20 mV, showed prominent inward rectification at depolarized potentials, were highly K ϩ selective (Na ϩ -to-K ϩ permeability ratio ϭ 0.007), and were potently inhibited by IKr blockers. Astemizole, terfenadine, cisapride, and MK-499 inhibited cERG and human ERG (hERG) currents with IC50 values of 1.3, 13, 19, and 15 nM and 1.2, 9, 14, and 21 nM, respectively, and competitively displaced [
ion channels; acquired long QT syndrome, potassium ion channel; ventricular arrhythmia; canine ether-à -go-go-related gene THE ACQUIRED long QT syndrome occurs commonly as a result of drug inhibition of I Kr , the rapid delayed rectifier K ϩ current in human ventricular myocardium. The human ether-à -go-go-related gene (herg) K ϩ channel protein (hERG) (29, 35) underlies I Kr and plays a critical role in human myocardial repolarization (22, 23) . Mutations in herg are associated with both the congenital (LQT2; inherited) and the acquired (aLQT; drug induced) long QT syndrome and attendant fatal cardiac arrhythmias (19) .
Drug safety is a critical issue in the development of novel human therapeutic agents, and it is increasingly recognized that new and existing drugs have the potential to induce aLQT through unanticipated inhibition of hERG K ϩ channels. During the course of drug development, the safety of new drug candidates is addressed in several nonhuman models before human exposure. Canine models are important because of similarities in heart size and the vast knowledge of canine physiology. In vitro canine cardiac tissues are used to study drug effects on action potential morphology and refractoriness. In vivo canine models are used to assess the propensity of drugs to affect the electrocardiogram including the QT interval, an index of myocardial repolarization. However, the biophysics and pharmacology of canine ERG (cERG) are unknown. The purpose of this study was to define the functional and pharmacological properties of cERG heterologously expressed in HEK-293 cells.
MATERIALS AND METHODS

Molecular Biology
The cERG cDNA was provided by Dr. Joerg Zehelein (University Hospital, Heidelberg, Germany; Ref. 36) . cERG was subcloned into pcDNA3 (Invitrogen) between the HindIII and EcoRI sites downstream of the cytomegalovirus promoter to generate an expression vector, pcDNA3-cERG.
Cell Culture
HEK-293 cells were purchased from American Type Culture Collection and cultured in modified minimum essential medium (MEM-␣M) supplemented with 10% fetal bovine serum and penicillin-streptomycin (GIBCO). HEK-293 cells were transfected with pcDNA3-cERG with the use of Fu-GENE 6 transfection reagent (Roche). Selection started 2 days after transfection in medium containing 800 g/ml geneticin (G-418; GIBCO). After 3 wk of selection, single colonies were cloned with cloning cylinders. A total of 13 cloned colonies were scaled up and maintained in selection medium with 100 nM astemizole (Sigma). HEK-293 cells stably transfected with herg were obtained from Drs. Craig January and Gail Robertson (University of Wisconsin, Madison, WI; Ref. 37) .
Western Blot Analysis
For each cell line, 3 ϫ 10 5 cells were seeded in parallel 35-mm dishes and grown overnight to similar levels of confluence. The next day the medium was removed by aspiration, and the cells were washed twice with PBS, then directly lysed with 0.5 ml of Laemmli sample buffer (Bio-Rad) containing 1 l of protease inhibitor cocktail (Sigma). Onetwentieth of the cell lysate from each sample was boiled for 5 min and loaded onto a Novex NuPAGE 3-8% Tris-acetate gel (Invitrogen/Novex) and then electrophoretically transferred onto a 0.45-m nitrocellulose membrane. Western blot analysis was performed with the WesternBreeze chemiluminescent immunodetection system (Invitrogen/Novex) according to the manufacturer's instructions, and antibody specific to hERG (anti-hERG, APC-016; Alomone Labs) at a 1:200 dilution was used to detect the cERG and hERG proteins.
Immunostaining
The expression of cERG in the cells was detected by immunostaining with primary antibodies (anti-hERG, APC-016; Alomone Labs) as described previously (32) . Cells were plated at 40,000 cells/well onto a 16-chamber slide coated with poly-D-lysine and grown overnight to confluence. Cells were first fixed with 0.2 ml of cold 4% paraformaldehyde for 20 min and then washed four times with cold PBS. After incubation in blocking buffer (3% BSA, 3% normal goat serum, 0.1% Triton X-100 in PBS) for 1 h, primary antibody (anti-hERG) diluted 1:100 in blocking buffer was added to the cells and incubated for 1 h at room temperature. After being washed with PBS, secondary antibody (goat anti-rabbit IgG Cy3; Jackson Immunoresearch) diluted 1:500 in blocking buffer was added to the cells and incubated for 30 min at room temperature. The slides were washed six times with PBS, dried, and covered with Vectashield mounting medium with DAPI (Vector Labs).
Cell Preparation for Electrophysiology
HEK-293 cERG cell lines were grown to 80% confluence, washed two times with PBS, trypsinized with 0.05% trypsin-EDTA (GIBCO) for 2 min at 37°C, and resuspended in culture medium. Cells were studied within 8 h.
Voltage-Clamp Recording Methods
Cells for electrophysiological study were transferred to an 80-l recording chamber (RC-24; Warner Instrument) and superfused with a solution containing (in mM) 132 NaCl, 4 KCl, 1.2 MgCl 2, 1.8 CaCl2, 10 HEPES, and 11 glucose, pH 7.2, at a flow rate of 0.8 ml/min, allowing rapid solution changes. The temperature was maintained at 36 Ϯ 1°C with a water-jacketed preheating system and a DC-powered heating system (Cell MicroControls, Virginia Beach, VA). In some experiments, currents were recorded at room temperature of 23 Ϯ 1°C. K ϩ currents were recorded with the whole cell patch-clamp technique. An Axopatch 200A patch-clamp amplifier was connected to a Pentium PC computer (Compaq Deskpro 6000) through a Digidata 1200 interface (Axon Instruments, Foster City, CA). Patch pipettes were fabricated from capillary glass obtained from Kimble Products (0. 
Voltage-Clamp Data Analysis
Channel kinetics were evaluated by fitting time (t)-dependent currents appropriately normalized with exponential functions consisting of one or more terms
where i ϭ 1 or 2 and Ai and i represent the amplitude and time constants of the ith component, respectively. The fits were based on nonlinear least-squares methods. The goodness of fit was determined by examining the residuals and visual inspection. Voltage dependence of channel opening was estimated by fitting a form of a Boltzmann equation
where V m represents membrane potential, V1/2 is the membrane potential when tail current (I) normalized to maximum current amplitude (I max) (I/Imax) ϭ 0.5, and k is a slope factor. Alternatively, this equation can be written in terms of thermodynamic parameters
where ⌬G0 represents a non-voltage-dependent free energy term, z represents the number of gating charges, ␦ is the fraction of the electrical field, e is the fundamental charge of an electron, and K b and T are the Boltzmann constant and absolute temperature, respectively (1) .
Ionic selectivity of the cERG channels was determined by examining the reversal potential (E rev) at various extracellular K ϩ concentrations ([K ϩ ]o). Data were fit with the Goldman-Hodgkin-Katz equation
where R is the gas constant, T is temperature, F is the 
MK-499 Binding Assay
Cell membranes were prepared from HEK-293 cells constitutively expressing hERG or cERG. Cells were harvested and homogenized in Tris-EDTA buffer containing 50 mM Tris and 1 mM EDTA, pH 7.4. Homogenates were centrifuged at 45,000 g for 20 min at 4°C. The pellet was washed once in Tris-EDTA, centrifuged, resuspended at a concentration of 5 mg/ml in binding buffer containing (in mM) 71.5 NaCl, 60 KCl, 1 CaCl 2, 2 MgCl2, and 10 HEPES, pH 7.4, and stored at Ϫ70°C.
On the day of assay, cERG or hERG membranes were thawed and diluted to a concentration of 10 g/ml in binding buffer and 35 (5) where n H is the Hill coefficient.
RESULTS
Western Blot Analysis and Immunostaining of cERG Expressed in HEK-293 Cells
The individual clonal cells were screened initially for expression of cERG protein by Western blot analysis and immunostaining. With these methods, three cell lines that expressed high levels of cERG channel protein were selected and evaluated further with voltage clamp. All three selected lines had similar current densities and properties. One particular line (HEK-293 cERG no. 2) was chosen and used exclusively in this study for characterization of the functional and pharmacological properties of the expressed cERG current.
Western blot analysis of total protein was conducted on three HEK-293 cell lines: nontransfected (control), hERG stably transfected, and cERG stably transfected (Fig. 1) . Antibodies directed against the COOH terminus of hERG were used to probe the hERG and cERG protein. The antibodies recognized two bands of 155 and 135 kDa in HEK-293 hERG lines. The cERG and hERG cells displayed very similar bands consistent with the predicted identical size of the hERG and cERG proteins.
Immunostaining of the cell lines detected cERG protein expression in HEK-293 cERG cells. The protein level appeared especially high in the cERG cell membranes ( Fig. 2A) . A similar staining pattern was seen in HEK-293 hERG cells (Fig. 2B) but not in the HEK-293 control cells (Fig. 2C ).
Biophysical Properties of cERG K ϩ Current
Membrane potential-dependent channel activation. Figure 3 shows voltage-dependent properties of cERG current at 23°C. Figure 3A illustrates superimposed whole cell K ϩ currents recorded during voltage-clamp steps to different potentials. The holding potential was Ϫ80 mV; the cell was depolarized to membrane potentials ranging between Ϫ60 and ϩ50 mV for 2 s to activate cERG current, and the cell was then clamped to Ϫ50 mV to record deactivating tail currents. During depolarizing steps, an outward current was activated at voltages positive to Ϫ40 mV and the current amplitude increased to a maximum at ϩ10 mV. With increasing depolarization, the current amplitude decreased progressively. Outward deactivating K ϩ tail currents were observed during a return to Ϫ50 mV. Figure 3B plots the outward K ϩ current amplitude at the end of each depolarizing step. The apparent inward rectification has been commonly observed in hERG channels and is attributed to rapid voltage-dependent channel inactivation (5, 22, 24, 27, 29) . Normalized tail current amplitudes were used to construct voltageactivation curve as shown in Fig. 3B . The threshold voltage for opening or activation of cERG channels was near Ϫ50 mV, and channels were fully activated at membrane potentials near 0 mV. The averaged peak tail current density at a membrane potential of ϩ40 mV was 55 Ϯ 16.7 pA/pF at 23°C. The averaged halfmaximum activation voltage (V 1/2 ) and slope factor k derived by fitting a Boltzmann function (Eq. 2) to the data at 23°C were Ϫ7.8 Ϯ 2.4 and 8.2 Ϯ 0.7 mV, respectively (see Table 1 ).
Kinetics of cERG activation gating: effect of temperature. The properties of channels measured at 36°C are more representative of native channel behavior under normal physiological conditions. Most experiments reported here were conducted at 36°C. Figure 4A shows an example of the effect of temperature on cERG K ϩ currents. The channels were forced to open (activated) by a 4-s step to 0 mV and then closed again by stepping to Ϫ50 mV. The ensemble kinetics of channel activation at 0 mV and the kinetics of channel closing at Ϫ50 mV can be seen. Increasing the temperature from 23°C to 36°C resulted in several changes. There was a marked increase in the amplitude of the K ϩ current. This coincided with a prominent acceleration of the rate of activation during the depolarization to 0 mV as well as an increase in the ensemble average kinetics of channel closing at Ϫ50 mV. The increase in K ϩ current at 36°C can be attributed in large part to the accelerated kinetics of channel opening (Table 2) . Depending on test voltage, a single-or double-exponential function (Eq. 1) was best fit to the activation and deactivation of the cERG current. At comparable voltages, elevating the temperature decreased both the fast ( f ) and slow ( s ) time constants of activation and deactivation and increased the relative contribution of f to each. For example, at a test potential of Ϫ20 mV, the averaged f and s of activation were 284 and 3,772 ms at 23°C, respectively, and these were decreased to 128 and 664 ms, respectively, at 36°C. In this instance, the fractional contribution of f to the activation process [A f / (A f ϩ A s )] increased from 0.15 to 0.43 (n ϭ 4). Likewise, at Ϫ50 mV, the averaged f and s of deactivation were 440 and 2,075 ms, respectively, at 23°C and were decreased to 109 and 653 ms, respectively, at 36°C, whereas [A f /(A f ϩ A s )] increased from 0.40 to 0.62 (n ϭ plots of the normalized current density (pA/pF) relations for the peak tail current on repolarization (Vtail) to Ϫ50 mV and time-dependent current measured at the end of the test pulse for the cell in A. Data are normalized to cell capacitance. Note that the time-dependent current displays prominent inward rectification at Vt greater than or equal to ϩ10 mV, characteristic of native delayed rectifier K ϩ current and expressed hERG current. 4). A plot of the effects of temperature on the voltageactivation curve is shown in Fig. 4B . Cooling from near body temperature (36°C) to room temperature (23°C) stabilized the closed state of the channel by ϳ18 kJ/ mol, shifting the V 1/2 from Ϫ31.9 to Ϫ7.8 mV, while k increased slightly from 6 to 8.2 mV (Table 1) .
A quantitative analysis of the time courses of cERG activation and deactivation is displayed in Fig. 5 , and the derived time constants are listed in Table 3 . The activation time courses between Ϫ40 and ϩ60 mV were measured by two methods. First, at membrane potentials Յ0 mV, the rising phase of the K ϩ current traces were fit directly with a double-exponential function (22, 25) as shown in Fig. 5A . At membrane potentials Ͼ0 mV, activating currents were not adequately described by a simple exponential function, most likely because of coincident rapid inactivation (10, 24, 27, 33) . Consequently, the time courses of activation at membrane potentials Ն0 mV were estimated by an "envelope of tails" method (16) . In an effort to kinetically separate these two processes, an envelope of tail currents was obtained with a voltage-clamp pulse protocol consisting of depolarizing steps applied for varying durations, followed by a repolarizing step to Ϫ50 mV to record K ϩ current tails. The peak amplitude of the K The rate of channel closing (deactivation) was determined by fitting the K ϩ current tails with a doubleexponential function. This is exemplified in Fig. 5C , which shows a cERG K ϩ current tail recorded at Ϫ70 mV after an initial depolarizing step to ϩ60 mV for 1 s. The voltage dependence of the f and s of deactivation are summarized in Table 3 along with the relative amplitudes [A f /(A f ϩ A s )] of the two components derived from the curve fitting. The data show that both the fast and slow components of deactivation were highly voltage dependent and that the fast component was greater at more negative membrane potentials. In contrast, the slow component was dominant at more positive membrane potentials. A summary of the time constants derived in this manner from five to eight cells is plotted in Fig. 5D , and the statistical averages are provided in Table 3 . The time constants were voltage dependent, ranging from ϳ20 ms at Ϫ80 mV to an average of 79 ms at Ϫ40 mV. At more positive membrane potentials up to ϩ60 mV the time constants decreased further to ϳ10 ms (Table 4 ; Refs. 25, 37). Currents were elicited from a Vh of Ϫ80 mV with a 4-s depolarizing step to a Vt of 0 mV. Repolarizing tail current was measured at Ϫ50 mV. B: plots of the voltage dependence of activation. Peak amplitude of deactivating tail currents were measured at Ϫ50 mV after 4-s steps to Vt ranging from Ϫ60 to ϩ50 mV. Tail currents were normalized to maximum current amplitude for each cell. A Boltzmann function (Eq. 3, MATERIALS AND METHODS) was fit to the averaged data with a nonlinear least-squares fitting routine. T, absolute temperature; ‚‚G, free energy. Values are means Ϯ SE. Values were collected at room temperature (23°C) in each of 4 cells and then heated to 36°C and remeasured. Deactivation values were determined after a test pulse to 0 mV. f, Fast time constant of activation; s, slow time constant of activation; Af/(Af ϩ As), fractional contribution of f to activation process.
cERG inactivation and recovery from inactivation. hERG channels undergo rapid voltage-dependent inactivation at depolarized membrane potentials and recover rapidly on repolarization (24, 27) . We tested for these characteristics in cERG channels with a threepulse protocol (shown in Fig. 6A ) to measure the rate of channel inactivation and a two-pulse protocol (Fig. 6B ) to measure recovery from inactivation. The three-pulse voltage-clamp protocol allows an estimate of the time constant of inactivation directly (6, 24, 25, 27, 33) .
The characteristics of cERG inactivation and recovery from inactivation are shown in Fig. 6 . cERG current was activated and inactivated by 200-ms depolarizing steps to ϩ60 mV. The cell was then repolarized to Ϫ100 mV for 2 ms to allow for recovery from inactivation without significant deactivation of cERG current (27) . Finally, a test step was applied to different voltages to measure inactivation of cERG current. The example in Fig. 6A shows that currents elicited by this protocol were large in amplitude and inactivated rapidly. The time constants of inactivation at the different membrane potentials were estimated by fitting a single-exponential function (Eq. 1). These time constants are plotted in Fig. 6C (n ϭ 3-6 cells) .
The time constants for recovery from inactivation were measured with a two-pulse protocol ( Fig. 6B ; see also Refs. 25, 27) . A cell was depolarized to ϩ60 mV for 200 ms to activate and inactivate cERG channels; the cell membrane was then repolarized to potentials between Ϫ20 and Ϫ100 mV. The rapid recovery of cERG current was estimated with a single-exponential fit to the tail current rising phase. The data from multiple cells are summarized and plotted in Fig. 6C . Both the rates of inactivation and the recovery from inactivation Fig. 5 . Time course of cERG current activation and deactivation. A: time course of activation was measured by 2 methods at Vt Ն 0 mV, by fitting both the activating current and the envelope of tail currents during a given depolarizing voltage step. Determination of activation time constants () used a single-exponential equation to fit (solid lines) both the current trace ({) and peaks of the tail currents (E) during a step to a Vt of 0 mV. In this example ϭ 39.9 and 31.5 ms, respectively. B: envelope of tail currents was generated by varying the duration of the voltage step from a Vh of Ϫ80 mV to Vt ϭ 0 mV and measuring the peak tail current on repolarization to Ϫ60 mV. C: deactivation time course on return to a Vtail of Ϫ70 mV after a depolarizing voltage step to a Vt of ϩ60 mV (see also Fig. 7 ), also best defined by fitting a dual-exponential equation (solid line) to the deactivating current trace (‚). D: plots of activation (n ϭ 4-8) and deactivation (n ϭ 7) time constants vs. test voltages. At Vt Ͻ 0 mV the activation time course was best defined by fitting a double-exponential equation to the activating current traces, thereby generating two activation values. Data were obtained at 36°C. were dependent on membrane potential, as seen in Fig.  6C . The time constants of inactivation and recovery ranged between 0.4 and 5 ms depending on membrane potential, and inactivation was much faster than activation of the channel.
Open channel conductance and K ϩ selectivity. A fully activated current-voltage (I-V) relationship for cERG channels is shown in Fig. 7 . cERG current was activated by a depolarizing step to ϩ60 mV for 1 s followed by steps to different membrane potentials, as shown in Fig. 7A . The rationale for this protocol is to open all channels, allowing K ϩ conductance, and then quickly change the membrane potential to measure the effect of a change in the electrochemical driving force on K ϩ current through the open channels. At the more positive membrane potentials, cERG current showed apparent inward rectification due to rapid inactivation and the current amplitude was relatively time inde- Values are means Ϯ SE. Adapted from Zhou et al. (37) . Fig. 6 . Time course of inactivation and recovery from inactivation. A: a 3-stage voltage-clamp protocol (inset) was used to study inactivation of cERG current. First, a cell was voltage clamped at a Vh of Ϫ80 mV and then depolarized to a prepotential of ϩ60 mV for 200 ms to activate and partially inactivate cERG current. Next, the cell was briefly repolarized to Ϫ100 mV for 2 ms to allow recovery from inactivation without significant deactivation of cERG current and finally depolarized to different voltages to inactivate cERG channels. B: recovery from inactivation was studied using a 2-step protocol (inset). Cells were depolarized for 200 ms to ϩ60 mV from a Vh of Ϫ80 mV to activate and inactivate cERG channels and then repolarized to varying voltages to examine the time course of recovery from inactivation. Only current traces during these latter steps to different voltages are shown on an expanded time scale. A single-exponential equation provided the best fit to the cERG current inactivation and recovery from inactivation time courses. C: voltage dependence of the time constants () for the development of inactivation and recovery from inactivation as a function of membrane potential at 36°C. pendent. During steps to more negative membrane potentials, cERG channels rapidly recovered from inactivation to reach a peak value followed by voltagedependent decay. Figure 7B shows the I-V plot of the peak tail currents observed at the membrane potentials indicated in the abscissa. This relationship demonstrates the apparent inward rectification at membrane potentials positive to Ϫ30 mV, with maximum outward current obtained at voltages between Ϫ20 and Ϫ30 mV. In the standard solutions used in these studies, K ϩ current recorded at membrane potentials more positive than Ϫ85 mV was outward, whereas at more negative membrane potentials the current was inward, defining the E rev under these conditions.
The K ϩ selectivity of cERG channels was estimated by determining the E rev of the tail current at varying [K ϩ ] o . Tail currents were measured with a protocol similar to that in Fig. 7A . Cells were voltage clamped to a test potential of ϩ60 mV for 500 ms followed by repolarizing voltage steps incremented in 5-mV steps between Ϫ110 and Ϫ45 mV. E rev was determined in each cell as the zero current intercept of the plot of tail current amplitude and was determined at [K ϩ ] o of 2, 4, and 10 mM. E rev were Ϫ98.5 Ϯ 0.8 (n ϭ 6 cells), Ϫ84.2 Ϯ 0.7 (n ϭ 6 cells), and Ϫ61.3 Ϯ 0.6 (n ϭ 4 cells) mV at 2, 4, and 10 mM [K ϩ ] o , respectively, and when corrected for the 4.9-mV junction potential in the recording system, the measured values were Ϫ103, Ϫ89, and Ϫ66 mV, respectively. is lowered, other partially permeant ions such as Na ϩ influence the measured E rev . This is predicted by the Goldman-Hodgkin-Katz equation (Eq. 4), which provided an excellent fit to these data (not shown). Assuming that K ϩ and Na ϩ are the major permeant ions, P Na /P K was 0.007. These data indicate a very high, but not absolute, K ϩ selectivity for the cERG channel. Although we did not extensively characterize the ionic selectivity of these channels with multi-ion substitutions, our estimate of P Na /P K at physiological concentrations should be a reasonable estimate of K ϩ selectivity given that Na ϩ was present at more than 30-fold excess compared with K ϩ .
cERG Pharmacology
Inhibition of cERG K ϩ current. To explore the pharmacology of cERG K ϩ channels, we tested the ability of a number of drugs known to inhibit hERG channels, including MK-499, astemizole, terfenadine, and cisapride. These agents represent chemically and structurally diverse compounds from different therapeutic classes. Each has been shown to inhibit hERG channels or I Kr in native cardiac myocytes (3, 4, 11, 13, 14, 20, 21, 26, 28, 38) . Figure 8 compares inhibition of cERG (Fig. 8A) and hERG (Fig. 8B) by MK-499. Whole cell K ϩ currents are shown at different membrane potentials in control (no drug) or 30 or 100 nM MK-499.
MK-499 potently inhibited both the canine and human channels. Normalized K ϩ current tails are plotted as a function of membrane potential in Fig. 8, C and D . In each case, K ϩ current in the presence of MK-499 at the concentration shown was normalized to the predrug control. MK-499 at 30 nM inhibited Ͼ50% of the current, and this effect appeared to be independent of membrane potential. Comparison of the inhibition of cERG and hERG channels by MK-499 is shown as concentration-effect curves in Fig. 8E . Data were fit with a Hill equation (Eq. 5) to estimate an IC 50 for each condition. The best-fitting IC 50 values derived from this type of analysis for MK-499, astemizole, terfenadine, and cisapride are listed in Table 5 . Voltage-activation relationships were generated from a Vh of Ϫ80 mV with 1-s depolarizing steps to Vt ranging from Ϫ60 to ϩ50 mV in 10-mV increments, and deactivating tail currents were measured during repolarization to Ϫ50 mV at 36°C (inset in A). Data were obtained at apparent steady state (5-8 min) for each concentration of MK-499 at 36°C. Normalized I-V plots of cERG (C) and hERG (D) tail currents during control and after MK-499 at 30 and 100 nM, respectively (n ϭ 4-6) are also shown. E: concentration dependence of cERG and hERG channel inhibition by MK-499. Inhibition of peak repolarizing tail current after a step to a Vt of ϩ40 mV is shown. Peak outward tail currents were measured for each drug concentration and expressed as a fraction of the control value in the same cell. Best-fit IC50 values obtained by nonlinear leastsquares regression of the Hill equation (Eq. 5) on individual data are shown (n ϭ 3-7). The solid curve is drawn arbitrarily based on the average IC50.
Inhibition of [ 35 S]MK-499 binding to cERG channels.
The binding site of MK-499 on the hERG channel subunit has been located with alanine scanning mutagenesis and homology modeling (12) . Here we compared standard hERG blockers for inhibition of [ 35 S]MK-499 binding to cERG and hERG channels. Figure 9 shows the concentration-dependent displacement of [ 35 S]MK-499 binding by MK-499, astemizole, terfenadine, and cisapride. The apparent affinity of each of these agents is consistent with the degree of inhibition of the expressed current in the voltageclamp studies (Table 5) .
DISCUSSION
In this study, we have established HEK-293 cell lines that stably express high levels of functional cERG channels and have characterized their biophysical and pharmacological properties. To our knowledge, this is the first comprehensive evaluation of the properties of cERG in a mammalian expression system at physiological temperature. We also have developed a novel methanesulfonanilide ([ 35 S]MK-499) binding assay and compared displacement of binding with block of K ϩ current under voltage clamp. We found that cERG channels are kinetically complex, with biophysical properties suitable to control myocyte repolarization. The properties of cERG channels are comparable to those of cardiac I Kr (15) and hERG (37) .
The gene cerg encodes a protein (cERG) that consists of 1,159 amino acids with 97% identity to hERG (36) . Notably, all amino acid differences are outside of the S2-S6 and P domains of the channel protein. Immunoblot analysis revealed two protein bands (155 and 135 kDa) that were each slightly larger than the predicted molecular mass of the core protein (127 kDa) based on nucleotide composition. Zhou et al. (37) reported similar findings for hERG and found that Nglycosidase F treatment of hERG converted both bands to apparent smaller molecular mass, suggesting that both proteins are glycosylated.
Zhou et al. (37) previously established stably transfected HEK-293 cell lines expressing functional hERG channels and characterized their electrophysiological and pharmacological properties. At 35°C, hERG current activated at voltages positive to Ϫ50 mV, maximum outward K ϩ current was reached at ϩ10 mV, and the outward current amplitude decreased at more positive voltages. The hERG channels were highly selec- tive for K ϩ . Voltage-dependent activation of cERG channels occurred between Ϫ50 and Ϫ10 mV, and the channels were highly K ϩ selective at 36°C. Most studies with hERG channels expressed in Xenopus oocytes or mammalian cells have been performed at room temperature (ϳ23°C) (22, 25, 29, 33) . Compared with 23°C, cERG current amplitude was increased approximately twofold at 36°C, and the kinetic properties were altered. The greatest temperature effect was on the rate of channel activation. Warming channels from room to body temperature shifted the equilibrium between closed and open states in favor of channel opening by nearly 20 kJ/mol (⌬⌬G ϭ Ϫ4.4 kcal/mol). Zhou et al. (37) observed a similar increase in hERG current on heating from 23°C to 35°C. Activation, inactivation, recovery from inactivation, and deactivation kinetics were faster at 36°C than at 23°C and closely resembled those of native I Kr at physiological temperatures. These findings characterize the functional properties of cERG channels and emphasize the complexity of the kinetic steps underlying channel gating that is highly temperature dependent.
We can also compare our results with findings reported for native I Kr . Studies of the native current are complicated because of its small size and the numerous other ionic currents active in the same range of membrane potentials in native myocytes (15) . For these reasons, native I Kr usually requires pharmacological separation. A detailed study of human I Kr in atrial cells was conducted by Wang et al. (34) . In their study, the E-4031-sensitive current activation data at 36°C (pharmacological isolation of I Kr ) had voltage and time dependence similar to our findings obtained with cERG at 36°C and those of Zhou et al. (37) for hERG. Veldkamp and co-workers (30) studied I Kr in human ventricular cells and reported an average activation time constant near 100 ms at ϩ30 mV. In myocytes from some mammalian species studied at physiological temperatures, e.g., guinea pig ventricular cells (23) or canine ventricular cells (9) , the time and voltage dependence of I Kr activation are also close to what we found with cERG, although in other species such as rabbit ventricular cells (2), slower activation kinetics values have been reported. Apparent differences in kinetics between ERG current and I Kr , a concern in several previous reports, are far less at physiological temperatures and may in fact be accounted for by slight variations in experimental conditions including ionic composition of solutions, cell type, and temperature.
Zehelein et al. (36) recently examined, in limited detail, the properties of cERG and hERG expressed in Xenopus oocytes. In that expression system at 20°C, they reported V 1/2 values of Ϫ36.6 and Ϫ30.8 mV for cERG and hERG, respectively. These estimates are substantially more negative than values for cERG and hERG obtained in this study in HEK-293 cells at 23°C and in other studies for hERG expressed in HEK-293 (37) or CHO (37) cells. The value of Ϫ30.8 mV is also much more negative than the V 1/2 of Ϫ15.1 mV originally reported for hERG expressed in Xenopus oocytes (22) . The reason for these differences is unclear.
Pharmacological inhibition of I Kr in ventricular myocytes or hERG channels leads to the development of aLQT and the potentially lethal polymorphic ventricular arrhythmia torsades de pointes. In this study we have chosen four agents known to prolong QT interval in humans and dogs for pharmacological evaluation on cERG channels. These include a prototypical methanesulfonanilide class III antiarrhythmic (MK-499), two antihistamines (astemizole and terfenadine), and a gastrointestinal prokinetic agent (cisapride). Notably, the latter three prescription drugs have been withdrawn from the U.S. market because of their potential for causing aLQT and sudden death due to arrhythmia.
Previous studies defined the potencies of these agents in various test systems including I Kr In this study, the potency for each of the agents was comparable between hERG and cERG within a given assay, i.e., measurement of expressed current or MK-499 binding (Table 5 into primarily the open or inactivated state. It has been postulated that ERG channels may undergo both slow and ultraslow (minutes) processes of inactivation (17) , and this latter inactivation process would be favored in the binding assay but essentially absent under our voltage-clamp conditions. This could increase the apparent affinity estimate for MK-499 but not for the other non-methanesulfonanilides in the binding assay. Differences in the kinetics of the on-rate for MK-499 compared with the other agents may also influence the ultimate apparent binding affinity estimate expressed as an IC 50 . In voltage-clamp experiments the drug washin period was of necessity limited to Ͻ10 min with application of test pulses at 0.1 Hz. If full equilibration between the drug and the highest affinity state of the channel did not occur under these conditions, then the apparent affinity would be reduced. Nevertheless, there was for the most part good agreement among the assays and the rank order of potency was preserved.
In conclusion, this study defines in detail the functional and pharmacological properties of cERG channels in a mammalian expression system and shows that the canine channel is biophysically and pharmacologically similar to the human channel and the K ϩ current is similar to native canine I Kr . The results suggest that canine ERG is a reasonable surrogate for the human channel. The MK-499 binding displacement assay robustly detected electrophysiologically active compounds and provides a novel tool for detection of drugs affecting ERG channels. Discrepancies in the ability of known inhibitors of hERG to prolong QT in canine models in vivo cannot be best explained by differences at the molecular/channel level but are more likely due to other factors.
